News | January 12, 2026
Aragen slashes drug development time with CHOMax platform
CHOMax integrates cell line development, process development, analytics, and GMP manufacturing under robust quality processes
CHOMax integrates cell line development, process development, analytics, and GMP manufacturing under robust quality processes
The multimillion-dollar facility combines discovery and early-phase scale-up capabilities with R&D labs and two pilot plants
New 35,000-square-foot facility in Winter Park will expand RLT manufacturing footprint to optimize delivery for patients across southeastern US
Shonan iPark was chosen for its globally connected life-science ecosystem, which unites pharmaceutical firms, next-generation medicine developers, AI and digital health innovators, venture capital, and academia
This partnership strengthens LMS as a leading CDMO supplier of peptide materials for both innovator and generic markets
Growing patent filings and tier-2 innovators reflect expanding national research base
Selected proposals in the innovation challenge will receive funding to develop transformative ideas, tools, and approaches to strengthen early diagnosis and improve patient outcomes
The State’s PPP model has already mobilised Rs. 150 crore in core infrastructure, while Thermo Fisher has invested Rs. 90 crore in the Bioprocess Design Centre and its co-located Customer Experience Centre
The company says the innovation delivers stronger moisture protection for highly sensitive drug molecules
The initiative aims to connect startups and tech companies with its business units,
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
